Summary
- Current Price
- As of today, INDV price is $39.80, down -1.12% on
- Current Price All-Time High
- INDV price is currently -7.03% below its historical high of $42.81 set on
- Market Cap
- INDV current market cap is $5B, up +144.23% over the past 365 days
- PE Ratio
- INDV current PE ratio is 20.16
- Revenue
- INDV current annual revenue is $1.24B, up +4.29% year-over-year
- Next Earnings
- The next earnings release for INDV is on
Profile
| Metric | Value |
|---|---|
| Full Name | Indivior Pharmaceuticals, Inc. |
| Ticker | NASDAQ: INDV |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | indivior.com |
| Employees | 827 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $39.80 | |
| Price, 1D Change | -1.12% | |
| $5B | ||
| - | ||
| 20.16 | ||
| 0.44 | ||
| $1B | ||
| Revenue, 1Y Change | +4.29% | |
| $1.64 | ||
| EPS, 1Y Change | +3,019.01% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.48 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:5 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| $1.64 | ||
| EPS Estimate | N/A | $3.82 |
| EPS Est. Change | N/A | +133.13% |
| $1.24B | ||
| Revenue Estimate | N/A | $1.26B |
| Revenue Est. Change | N/A | +1.53% |
| Current Price | $39.80 | |
| Price Target | - | $50.00 |
| Price Tgt. Change | - | +25.63% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.61 | $0.05 | -96.74% | |
| $2.33 | $1.64 | -29.68% | |
| $3.82 | N/A | +133.13% | |
| $4.14 | N/A | +152.48% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.15B | $1.19B | +3.15% | |
| $1.19B | $1.24B | +4.05% | |
| $1.26B | N/A | +1.53% | |
| $1.31B | N/A | +5.56% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $39.80 | |
| $32.77 | ||
| $37.73 | ||
| $32.03 | ||
| $37.58 | ||
| $1.06 | ||
| 0.44 | ||
| $1.46 | ||
| 56.21 | ||
| 33.45% | ||
| 39.62% |
Dividends
| Metric | Date | Value |
|---|---|---|
| Last Paid | $0.48 | |
| Upcoming | N/A | N/A |
| - | ||
| Total Dividend | - | |
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $1.24B | ||
| $1.64 | ||
| $993.00M | ||
| 80.15% | ||
| $262.00M | ||
| 21.15% | ||
| $210.00M | ||
| 16.95% | ||
| $282.00M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| -3.58 | ||
| 0.71 | ||
| 0.55 | ||
| - | ||
| 4 | ||
| 3.37 |
Valuations
| Metric | Date | Value |
|---|---|---|
| 20.16 | ||
| 3.64 | ||
| -32.67 | ||
| 11.35 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| -$98.00M | ||
| $195.00M | ||
| $1.20B | ||
| $652.00M | ||
| $1.30B | ||
| $914.00M | ||
| $351.00M | ||
| $39.00M | ||
| $250.00M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $1.03B | ||
| $731.00M | ||
| $246.00M | ||
| $634.00M | ||
| $20.00M | ||
| $0.00 | ||
| $29.00M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$27.00M | ||
| -$66.00M | ||
| -$30.00M | ||
| $67.00M | ||
| -$94.00M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Barclays | ||
| HC Wainwright & Co. | → | |
| Piper Sandler | → | |
| HC Wainwright & Co. | → | |
| Craig-Hallum | → | |
| HC Wainwright & Co. | ||
| Craig-Hallum | → | |
| Piper Sandler | → | |
| Piper Sandler | → | |
| Piper Sandler | → |
Analyst sentiment
Institutional ownership
Screeners with INDV
FAQ
What is the ticker symbol for Indivior Pharmaceuticals, Inc.?
The ticker symbol for Indivior Pharmaceuticals, Inc. is NASDAQ:INDV
Does Indivior Pharmaceuticals, Inc. pay dividends?
No, Indivior Pharmaceuticals, Inc. does not pay dividends
What sector is Indivior Pharmaceuticals, Inc. in?
Indivior Pharmaceuticals, Inc. is in the Healthcare sector
What industry is Indivior Pharmaceuticals, Inc. in?
Indivior Pharmaceuticals, Inc. is in the Specialty & Generic Drug Manufacturers industry
What country is Indivior Pharmaceuticals, Inc. based in?
Indivior Pharmaceuticals, Inc. is headquartered in United States
When did Indivior Pharmaceuticals, Inc. go public?
Indivior Pharmaceuticals, Inc. initial public offering (IPO) was on December 29, 2014
Is Indivior Pharmaceuticals, Inc. in the S&P 500?
No, Indivior Pharmaceuticals, Inc. is not included in the S&P 500 index
Is Indivior Pharmaceuticals, Inc. in the NASDAQ 100?
No, Indivior Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
Is Indivior Pharmaceuticals, Inc. in the Dow Jones?
No, Indivior Pharmaceuticals, Inc. is not included in the Dow Jones index
When was Indivior Pharmaceuticals, Inc. last earnings report?
Indivior Pharmaceuticals, Inc.'s most recent earnings report was on April 30, 2026
When does Indivior Pharmaceuticals, Inc. report earnings?
The next expected earnings date for Indivior Pharmaceuticals, Inc. is August 6, 2026
Data Sources & References
- INDV Official Website www.indivior.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1625297/000162828026012237/0001628280-26-012237-index.htm
- INDV Profile on Yahoo Finance finance.yahoo.com/quote/INDV
- INDV Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/indv